EMEA-000816-PIP02-10-M03
Key facts
| Invented name |
Izinova (and associated names)
|
| Active substance |
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0159/2022
|
| PIP number |
EMEA-000816-PIP02-10-M03
|
| Pharmaceutical form(s) |
Concentrate for oral solution
|
| Condition(s) / indication(s) |
Diagnostic of organic and/or functional bowel diseases
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
IPSEN Consumer Healthcare
Email: ch_ra@ipsen.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|